References for "Delusions of infestation"

Freudenmann RW, et al. "Delusional Infestation," Clinical Microbiology Review (Oct. 2009): Vol. 22, No. 4, pp. 690–732. Freudenreich O, et al. "Morgellons Disease, or Antipsychotic-Responsive Delusional Parasitosis, in an HIV Patient: Beliefs in the Age of the Internet," Psychosomatics (Nov. 2010): Vol. 51, No. 6, pp. 453–57. (Locked) More »

References for "Metabolic syndrome and mental illness"

"Advancing the Treatment of People with Mental Illness: A Call to Action in the Management of Metabolic Issues," Journal of Clinical Psychiatry (June 2005): Vol. 66, No. 6, pp. 790–98. Baptista T, et al. "Metformin as an Adjunctive Treatment to Control Body Weight and Metabolic Dysfunction During Olanzapine Administration: A Multicentric, Double-Blind, Placebo-Controlled Trial," Schizophrenia Research (July 2007): Vol. 93, No. 1-3, pp. 99–108. Ehret M, et al. "The Effect of Metformin on Anthropometrics and Insulin Resistance in Patients Receiving Atypical Antipsychotic Agents: A Meta-Analysis," Journal of Clinical Psychiatry (Oct. 2010): Vol. 71, No. 10, pp. 1286–92. (Locked) More »

References for "New diagnostic criteria for Alzheimer's disease"

Albert MS, et al. "The Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease: Recommendations from the National Institute on Aging and Alzheimer's Association Work Group," Alzheimer's & Dementia (2011): Electronic publication ahead of print. Jack CR, Jr., et al. "Introduction to the Recommendations from the National Institute on Aging and the Alzheimer's Association Work Group on Diagnostic Guidelines for Alzheimer's Disease," Alzheimer's & Dementia (2011): Electronic publication ahead of print. McKhann GM, et al. "The Diagnosis of Dementia Due to Alzheimer's Disease: Recommendations from the National Institute on Aging and the Alzheimer's Association Work Group," Alzheimer's & Dementia (2011): Electronic publication ahead of print. (Locked) More »

References for "No 'magic pill' for autism spectrum disorders"

Aman MG, et al. "Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences," Journal of Child and Adolescent Psychopharmacology (Feb. 2005): Vol. 15, No. 1, pp. 116–26. Esbensen AJ, et al. "A Longitudinal Investigation of Psychotropic and Nonpsychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders," Journal of Autism and Developmental Disorders (Sept. 2009): Vol. 39, No. 9, pp. 1339–349. Krishnaswami S, et al. "A Systematic Review of Secretin for Children with Autism Spectrum Disorders," Pediatrics (May 2011): Vol. 127, No. 5, pp. e1322–325. (Locked) More »

New diagnostic criteria for Alzheimer's disease

The National Institute on Aging and the Alzheimer's Association has published new guidelines for the diagnosis of Alzheimer's disease. This is the first update since the original guidelines were created in 1984. The guidelines include several significant changes. First, they describe three disease stages: asymptomatic (preclinical), thinking difficulties (mild cognitive impairment), and dementia (Alzheimer's). This is the first formal recognition of what research has suggested for several years now — that Alzheimer's disease evolves gradually over many years and that physiological changes in the brain occur a decade or more before noticeable symptoms such as memory loss or behavioral changes. Second, the guidelines propose — for research purposes only — using biomarker tests in conjunction with clinical assessments to determine whether someone might be at an early stage of Alzheimer's. The biomarkers are still being tested, however, and are not meant for routine use in a clinical setting. Finally, the guidelines emphasize that although Alzheimer's usually involves memory loss, in some cases it will cause other symptoms first — such as difficulty in finding the right words for something or problems seeing the "big picture" in a situation. Investigators, clinicians, and policy makers are hoping the guidelines will help accelerate research on ways to prevent or at least slow the progression of Alzheimer's.  (Locked) More »

No "magic pill" for autism spectrum disorders

Surveys indicate that nearly half of children with autism spectrum disorders take some type of psychiatric medication — most often antidepressants, antipsychotics, or stimulants. Yet a federally funded study concluded that most of these drugs aren't effective at treating symptoms of autism spectrum disorders. Early intervention behavioral therapy, typically delivered at home or in school, forms the foundation of treatment for autism spectrum disorders. Unfortunately these therapies are labor- and time-intensive, producing modest improvements at best. Parents and clinicians, often desperate for additional options, have increasingly turned to medications to alleviate symptoms such as aggression, irritability, and repetitive behaviors, or to prevent children from injuring themselves. In an effort to provide clinicians and parents with better information to guide treatment decisions, the U.S. Agency for Healthcare Research and Quality asked investigators at the Vanderbilt University Evidence-Based Practice Center to conduct a review of research on various autism spectrum disorder treatments for children 12 and younger. (Locked) More »

Metabolic syndrome and mental illness

People with metabolic syndrome are five times more likely than healthy adults to develop diabetes and twice as likely to develop heart disease. Although metabolic syndrome affects nearly a quarter of all Americans — roughly 50 million people — those with mental illnesses like schizophrenia or bipolar disorder are especially vulnerable. Antipsychotic medications in particular can cause significant weight gain. Other contributing factors include smoking, inadequate nutrition, lack of exercise, and limited access to quality health care. (Locked) More »

Delusions of infestation

Delusional parasitosis may occur on its own or as a complication of another disorder. It's enough to make your skin crawl, just thinking about it: insects, worms, fungi, or other pathogens colonizing a person's body. When there is no proof of actual infestation, however, the problem may be delusional parasitosis. This poorly understood disorder has gone by different names over the years, including Ekbom's syndrome (named for the first doctor to identify the phenomenon as a disorder), organic hallucinosis, unexplained dermopathy, and delusional infestation. The most recent manifestation of delusional parasitosis may be Morgellons, in which people believe they have been infested with fibers, threads, and other inanimate material. None of these names appears in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Instead, delusional parasitosis most closely resembles what the DSM-IV categorizes as delusional disorder, somatic type. Defined most simply, hallucinations are false perceptions, and delusions are false beliefs. Delusional parasitosis is a bit of a hybrid. The phenomenon involves both perception and belief. And the disorder's symptoms may be based on a misinterpretation of real sensations. This disorder may thus be related to paresthesia (Greek for abnormal sensation), akin to the feeling of "pins and needles." (Locked) More »